文献速递临床试验与 GCP

PANSAID-对乙酰氨基酚与NSAID联合用药:一项随机、盲法、平行、四组多中心临床试验的详细统计分析计划

PANSAID-PAracetamol and NSAID in combination: detailed statistical analysis plan for a randomised, blinded, parallel, four-group multicentre clinical trial.
PubMed 文献 · Trials · 2017-10-10

PANSAID试验是一项多中心、随机、对照、平行、四组临床试验,比较不同剂量和组合的对乙酰氨基酚与布洛芬在全髋关节置换术患者中的获益与危害。本文详细描述主要发表的统计分析计划,以防止结局报告偏倚和数据驱动分析结果。

要点

  • PANSAID试验比较对乙酰氨基酚与布洛芬不同剂量和组合在全髋关节置换术中的获益与危害。
  • 两个共同主要结局为术后24小时吗啡消耗量和术后90天内发生一次或以上严重不良事件的患者比例。
  • 次要结局包括术后6和24小时活动与静息时疼痛评分及术后24小时内发生一次或以上不良事件的患者比例。

核心结论

  • PANSAID试验将提供一项低偏倚风险的大型试验,评估围手术期对乙酰氨基酚与布洛芬联合用药的获益与危害。

研究设计与样本

  • 多中心、随机、对照、平行、四组临床试验,比较对乙酰氨基酚与布洛芬不同剂量和组合在全髋关节置换术患者中的获益与危害。
  • 患者、护理人员、医生、研究者和统计人员对干预设盲。

关键数值与推荐

  • 共同主要结局为术后24小时吗啡消耗量和术后90天内发生一次或以上严重不良事件的患者比例。
  • 次要结局为术后6和24小时活动与静息时疼痛评分,以及术后24小时内发生一次或以上不良事件的患者比例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Effective postoperative pain management is essential for the rehabilitation of the surgical patient. The PANSAID trial evaluates the analgesic effects and safety of the combination of paracetamol and ibuprofen. This paper describes in detail the statistical analysis plan for the primary publication to prevent outcome reporting bias and data-driven analysis results. METHODS/DESIGN: The PANSAID trial is a multicentre, randomised, controlled, parallel, four-group clinical trial comparing the beneficial and harmful effects of different doses and combinations of paracetamol and ibuprofen in patients having total hip arthroplastic surgery. Patients, caregivers, physicians, investigators, and statisticians are blinded to the intervention. The two co-primary outcomes are 24-h consumption of morphine and proportion of patients with one or more serious adverse events within 90 days after surgery. Secondary outcomes are pain scores during mobilisation and at rest at 6 and 24 h postoperatively, and the proportion of patients with one or more adverse events within 24 h postoperatively. DISCUSSION: PANSAID will provide a large trial with low risk of bias regarding benefits and harms of the combination of paracetamol and ibuprofen used in a perioperative setting. TRIAL REGISTRATION: ClinicalTrials.org identifier: NCT02571361 . Registered on 7 October 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Thybo KH, Jakobsen JC, Hägi-Pedersen D, et al. PANSAID-PAracetamol and NSAID in combination: detailed statistical analysis plan for a randomised, blinded, parallel, four-group multicentre clinical trial. Trials. 2017. PMID: 29017585. doi:10.1186/s13063-017-2203-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。